Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals, Inc.

RAFA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$789.9K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rafarma Pharmaceuticals, Inc.Rafarma Pharmaceuticals, Inc.3.4-4%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$789,903.00
Enterprise Value$747,903.00
Earnings per Share$0
Beta0.7
Outstanding Shares87,766,999

Return

Return on Equity3.76%ROE
Return on Assets3.26%
Return on Invested Capital5.13%

Valuation & Multiples

P/E Ratio3.43P/E Ratio
PEG8.18PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.08
Enterprise Value to EBIT1.39
Enterprise Value to Net Income1
Total Debt to Enterprise0.03
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Rafarma Pharmaceuticals, Inc.

700 employees
CEO: Sergey Brusnitsin

Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfol...